MICHELLE WOOD: Open Payments
NPI 1881110559 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,348 in 145 payments from 20 companies in 2025. Trend: 2023 $1,603 · 2024 $2,344 · 2025 $3,348
Food & beverage: $3,348
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 43 | $732 |
| Novartis Pharmaceuticals Corporation | 12 | $424 |
| ABBVIE INC. | 16 | $384 |
| AstraZeneca Pharmaceuticals LP | 10 | $239 |
| Lilly USA, LLC | 5 | $212 |
| UCB, Inc. | 10 | $195 |
| PFIZER INC. | 9 | $186 |
| Janssen Biotech, Inc. | 8 | $182 |
| E.R. Squibb & Sons, L.L.C. | 9 | $162 |
| GlaxoSmithKline, LLC. | 7 | $159 |
Products named: COSENTYX, SAPHNELO, OTEZLA, Bimzelx, RINVOQ, SKYRIZI, XELJANZ, TREMFYA.
Industry payments across NC — which companies pay providers there.
